Abstracts Archive - Page 1122 of 2425 - ACR Meeting Abstracts

Abstract Number: 1761 • 2018 ACR/ARHP Annual Meeting
Evaluation of the Functional Activity of Endothelial Progenitor Cells in Patients with ANCA-Associated Vasculitis
Ana Paula Toledo Del Rio¹, Stephanie Ospina Prieto¹, Bruno Kosa Lino Duarte¹, Manoel Barros Bertolo^1,2, Margareth de Castro Ozelo¹ and Zoraida Sachetto¹, ¹Internal Medicine, Faculty of Medical Science - State University of Campinas/Unicamp, Campinas, Brazil, ²INTERNAL MEDICINE, DISCIPLINE OF RHEUMATOLOGY, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil
Background/Purpose: ANCA-associated vasculitis (AAV) are relapsing diseases with high morbidity and mortality. The vascular damage present in these patients requires continuous repair with the participation…
Abstract Number: 1762 • 2018 ACR/ARHP Annual Meeting
Plasma iC3b Level As a Biomarker of Disease Relapse in ANCA-Associated Vasculitis
Catherine E. Najem¹, Martin Schmidt², Chad Stiening³, David Cuthbertson⁴, Simon Carette⁵, Nader A. Khalidi⁶, Curry L. Koening⁷, Carol Langford⁸, Carol A. McAlear⁹, Paul A. Monach¹⁰, Larry W. Moreland¹¹, Christian Pagnoux¹², Philip Seo¹³, Ulrich Specks¹⁴, Antoine G. Sreih¹, Steven R. Ytterberg¹⁵ and Peter A. Merkel^16,17, ¹Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Kypha, Inc., St. Louis, MO, ³Kypha, Inc., St Louis, MO, ⁴Biostatistics and Informatics, Department of Pediatrics, Department of Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, ⁵Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ⁶Rheumatology, McMaster University, Hamilton, ON, Canada, ⁷Rheumatology, Division of Rheumatology, University of Utah, Salt Lake City, UT, ⁸Rheumatic and Immunologic Diseases, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, ⁹Division of Rheumatology, University of Pennsylvania; Perelman School of Medicine, Philadelphia, PA, ¹⁰Section of Rheumatology, Boston University School of Medicine, Boston, MA, ¹¹Division of Rheumatology and Clinical Immunology, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ¹²Division of Rheumatology, Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ¹³Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ¹⁴Mayo Clinic College of Medicine, Rochester, MN, ¹⁵Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, ¹⁶Division of Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ¹⁷Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA
Background/Purpose:C3, the central protein of the complement cascade, participates in an amplification loop that can lead to complement deposition and host tissue damage. If elevated,…
Abstract Number: 1763 • 2018 ACR/ARHP Annual Meeting
Characterizing the Gut and Plasma Metabolomes in Patients with ANCA-Associated Vasculitis
Catherine E. Najem¹, Jung-Jin Lee², Ceylan Tanes², Cassidy Strange², Elliot Friedman², Antoine G. Sreih¹, Rennie L. Rhee¹, Abdallah Geara³, Hongzhe Li⁴, Kyle Bittinger², James D. Lewis⁵, Gary Wu⁵ and Peter A. Merkel⁴, ¹Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, ³Division of Nephrology and Hypertension, University of Pennsylvania, Philadelphia, PA, ⁴Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, ⁵Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA
Background/Purpose:To explore the mechanisms by which an altered gut microbiota might predispose to ANCA-associated vasculitis (AAV), a comprehensive metabolic profiling of fecal and plasma bile…
Abstract Number: 1764 • 2018 ACR/ARHP Annual Meeting
The Utility of Serum Angiopoietin-1 and Angiopoietin-2 in Patients with Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis
Yoko Wada¹, Takeshi Kuroda², Masaaki Nakano³ and Ichiei Narita¹, ¹Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, ²Health Administration Center, Niigata University, Niigata, Japan, ³Department of Medical Technology, School of Health Sciences, Faculty of Medicine, Niigata University, Niigata, Japan
Background/Purpose: Angiopoietin-1 (Ang-1) and Angiopoietin-2 (Ang-2) are antagonistic ligands which bind with similar affinity to the extracellular domain of the tyrosine kinase with Ig-like and…
Abstract Number: 1765 • 2018 ACR/ARHP Annual Meeting
Cerebrospinal Fluid Biomarker of Disease Activity: Significance in ANCA-Related Hypertrophic Pachymeningitis
Yasuhiro Shimojima¹, Dai Kishida² and Yoshiki Sekijima², ¹Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan, ²Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan
Background/Purpose: Hypertrophic pachymeningitis (HP), which becomes the cause of chronic headache, seizure, and cranial neuropathy, is an inflammatory disorder demonstrating focal and diffuse thickening of…
Abstract Number: 1766 • 2018 ACR/ARHP Annual Meeting
Abdominal Adipose Tissue Predicts Incident Major Cardiovascular Events in Systemic Necrotizing Vasculitis Patients: Data from a Prospective Cohort Study on 120 Patients
Soledad Henriquez¹, Bertrand Dunogué², Alexis Régent¹, Pascal Cohen³, Alice Bérezné¹, Sami Kolta⁴, Claire Le Jeunne¹, Luc Mouthon⁵, Christian Roux⁴, Loïc Guillevin⁶, Karine Briot⁷ and Benjamin Terrier⁸, ¹Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ²Internal Medicine, Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ³Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, ⁴Department of Rheumatology, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ⁵Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France, ⁶Medecine Interne, Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ⁷Department of Rheumatology, Cochin Hospital and Epidemiology and Biostatistics Unit,Sorbonne Paris Cité Reserach Center,Paris Descartes University,INSERM U1153, Paris, France, ⁸National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France
Background/Purpose: Cardiovascular (CV) events are highly prevalent in patients with systemic necrotizing vasculitides (SNV). The visceral/subcutaneous adipose tissue (VAT/SAT) ratio has been shown to be…
Abstract Number: 1767 • 2018 ACR/ARHP Annual Meeting
Occurrence and Etiology of Gastrointestinal Perforation in Patients with Vasculitis
Vanessa L. Kronzer¹, Daniel Larson², Cynthia S. Crowson^3,4, Kenneth J. Warrington⁵, Steven R. Ytterberg⁵, Ashima Makol⁴ and Matthew J. Koster⁴, ¹Internal Medicine, Mayo Clinic, Rochester, MN, ²Pathology, Mayo Clinic, Rochester, MN, ³Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁴Rheumatology, Mayo Clinic, Rochester, MN, ⁵Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN
Background/Purpose: This study aimed to characterize the presenting features and outcomes of patients with small- or medium-vessel vasculitis and gastrointestinal perforation. Methods: Using a retrospective…
Abstract Number: 1768 • 2018 ACR/ARHP Annual Meeting
Kidney Involvement, Poor Performance Status, and Higher Cumulative Dose of Glucocorticoid Are the Risk Factors of the Discontinuation of Immunosuppressant in Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Takamasa Murosaki, Takeo Sato, Katsuya Nagatani and Seiji Minota, Department of Internal Medicine, Division of Rheumatology/Clinical Immunology, Jichi Medical University, Shimotsuke, Japan
Background/Purpose: The use of immunosuppressant (IS) with glucocorticoid is recommended as remission induction treatment for severe cases with antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV).…
Abstract Number: 1769 • 2018 ACR/ARHP Annual Meeting
Efficacy and Safety of Biomimic Rituximab in Granulomatosis with Polyangiitis – Experience from a Single Tertiary Care Centre in India
Aman Sharma¹, Sakshi Mittal², GSRSNK Naidu³, Saket Jha², Manish Rathi⁴, Vikas Sharma², Arghya Chattopadhyay⁵, Varun Dhir⁶, Kusum Sharma⁷, Ranjana Minz⁸, Ritambhra Nada⁹ and Sanjay Jain¹⁰, ¹Clinical Immunology and Rheumatology Services, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, ²Internal Medicine, PGIMER, Chandigarh, India, ³PGIMER, cHANDIGARH, India, ⁴Department of Nephrology,, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ⁵PGIMER, Chandigarh, India, ⁶Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, ⁷Department of Medical Microbiology,, PGIMER,, Chandigarh, India, ⁸Department of Immunopathology,, PGIMER,, Chandigarh, India, ⁹Postgraduate Institute of Medical Education and Research, Chandigarh, India, ¹⁰Postgraduate Institute of Medical Education and Research, Chandigarh, India, CHANDIGARH, India
Background/Purpose: Though rituximab(RTX) has become a standard of care for remission induction and maintenance in Granulomatosis with Polyangiitis(GPA), there is very limited data on the…
Abstract Number: 1770 • 2018 ACR/ARHP Annual Meeting
Subglottic Stenosis and Endobronchial Disease in Granulomatosis with Polyangiitis
Kaitlin Quinn^1,2, Cailin Sibley³, Alexander Gelbard⁴, Arlene Sirajuddin⁵, Marcela A. Ferrada⁶, Marcus Chen⁷, David Cuthbertson⁸, Simon Carette⁹, Nader A. Khalidi¹⁰, Curry L. Koening¹¹, Carol Langford¹², Carol A. McAlear¹³, Paul A. Monach¹⁴, Larry W. Moreland¹⁵, Christian Pagnoux¹⁶, Philip Seo¹⁷, Ulrich Specks¹⁸, Antoine G. Sreih¹⁹, Steven R. Ytterberg²⁰, Peter A. Merkel²¹ and Peter C. Grayson²², ¹Georgetown University Hospital, Washington, DC, ²Systemic Autoimmunity Branch, NIAMS, Bethesda, MD, ³Oregon Health & Science University, Portland, OR, ⁴Vanderbilt University Medical Center, Nashville, TN, ⁵National Institutes of Health, Bethesda, MD, ⁶Critical Care, National Institutes of Health, Bethesda, MD, ⁷NHLBI, National Institutes of Health, Bethesda, MD, ⁸Biostatistics and Informatics, Department of Pediatrics, Department of Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, ⁹Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ¹⁰Rheumatology, McMaster University, Hamilton, ON, Canada, ¹¹Rheumatology, Division of Rheumatology, University of Utah, Salt Lake City, UT, ¹²Rheumatic and Immunologic Diseases, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, ¹³Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ¹⁴Section of Rheumatology, Boston University School of Medicine, Boston, MA, ¹⁵Division of Rheumatology and Clinical Immunology, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ¹⁶Division of Rheumatology, Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ¹⁷Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ¹⁸Mayo Clinic College of Medicine, Rochester, MN, ¹⁹Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ²⁰Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, ²¹University of Pennsylvania, Philadelphia, PA, ²²National Institute of Arthritis, Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD
Background/Purpose: Damage to the large airways is a devastating complication of granulomatosis with polyangiitis (GPA). Identification of patient subsets at particular risk for airway disease…
Abstract Number: 1771 • 2018 ACR/ARHP Annual Meeting
Long-Term Survival of Renal Transplantation in Rapidly Progressive Glomerulonephritis (RPGN). Study of 43 Cases from a Single Center
Belén Atienza-Mateo¹, Lara Sánchez-Bilbao¹, José Luis Martín-Varillas¹, Marina de Cos-Gómez², Íñigo González-Mazón¹, Diana Prieto Peña³, Monica Calderón Goercke³, Emilio Rodrigo Calabia², Juan Carlos Ruiz San Millán², Miguel Angel González-Gay¹ and Ricardo Blanco⁴, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Nephrology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain
Background/Purpose: Rapidly Progressive Glomerulonephritis (RPGN) is characterized histology by presence of crescents and clinically by rapid and severe decline in kidney function. Thus, it may…
Abstract Number: 1772 • 2018 ACR/ARHP Annual Meeting
Apremilast in Refractory Oral and/or Genital Ulcers in Behçet’s Disease. Multicenter Study of 37 Cases
Belén Atienza-Mateo¹, José Luis Martín-Varillas¹, Javier Loricera², Genaro Graña Gil³, Gerard Espinosa⁴, Clara Moriano Morales⁵, Trinidad Pérez-Sandoval⁶, Manuel Martín-Martínez⁶, Elvira Díez⁶, Maria Dolores Garcia Armario⁷, Ivan Castellví⁸, Francisca Sivera⁹, Jaime Calvo-Alén¹⁰, Isabel de la Morena¹¹, Francisco Ortiz-Sanjuán¹², José Andrés Román-Ivorra¹³, Ana Pérez Gómez¹⁴, Sergi Heredia¹⁵, Carolina Díez¹⁶, J Alegre¹⁷, Amparo Ybáñez¹⁷, Javier Narváez¹⁸, Ana Turrión Nieves¹⁹, Susana Romero-Yuste²⁰, Alejandro Olivé-Marqués²¹, Águeda Prior²², Esperanza Martínez⁷, Ignasi Figueras²³, Pilar Trénor²⁴, Carmen Gonzalez Vela²⁵, Diana Prieto Peña²⁶, Monica Calderón Goercke²⁶, José Luis Hernández², Miguel Angel González-Gay¹ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology Division, Complejo Hospitalario Universitario A Coruña. Spain, La Coruña, Spain, ⁴Department of Autoimmune Diseases, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁵Rheumatology, Complejo Asistencial Universitario de León. León. Spain, León, Spain, ⁶Rheumatology, Hospital Universitario de León. Spain, León, Spain, ⁷Rheumatology and Dermatology, Hospital Lluís Alcanyís. Valencia. Spain, Valencia, Spain, ⁸Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau. Barcelona. Spain, Barcelona, Spain, ⁹Rheumatology, Hospital General Universitario de Elda. Comunidad Valenciana. Spain, Elda, Spain, ¹⁰Rheumatology Department, Hospital Universitario Araba. Vitoria-Gasteiz, Alava, Spain, ¹¹Hospital General Universitario de Valencia. Spain, Valencia, Spain, ¹²Rheumatology, Hospital La Fe. Valencia. Spain, Valencia, Spain, ¹³Hospital La Fe. Valencia. Spain, Valencia, Spain, ¹⁴Rheumatology, Hospital Universitario Príncipe de Asturias. Alcalá de Henares. Madrid. Spain, Alcalá de Henares, Madrid, Spain, ¹⁵Rheumatology, Hospital Moisès Broggi-Hospital General de L´Hospitalet. Consorci Sanitari Integral,, Barcelona, Spain, ¹⁶Rheumatology, Hospital de El Bierzo. León. Spain, León, Spain, ¹⁷Rheumatology, Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, ¹⁸Rheumatology, Hospital Bellvitge. Barcelona. Spain, Barcelona, Spain, ¹⁹Rheumatology, Hospital Universitario de Salamanca. Spain, Salamanca, Spain, ²⁰Hospital de Pontevedra. Spain, Pontevedra, Spain, ²¹Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ²²Rheumatology, Hospital Universitari Germans Trias i Pujol. Barcelona. Spain, Barcelona, Spain, ²³Rheumatology and Dermatology, Hospital Bellvitge. Barcelona. Spain, Barcelona, Spain, ²⁴Rheumatology, Hospital Clínico Universitario de Valencia. Spain, Valencia, Spain, ²⁵Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²⁶Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Behçet´s disease (BD) is characterized by recurrent oral and/or genital ulcers accompanied by ocular, cutaneous, articular, gastrointestinal, and/or neurologic manifestations. Oral and/or genital aphthous…
Abstract Number: 1773 • 2018 ACR/ARHP Annual Meeting
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis Due to Behçet’s Disease. National Multicenter Study of 177 Cases
Belén Atienza-Mateo¹, José Luis Martín-Varillas¹, Vanesa Calvo-Río², Rosalía Demetrio-Pablo³, Emma Beltrán⁴, Marina Mesquida⁵, Alfredo Adan⁵, Juan Sánchez Bursón Sr.⁶, M. Victoria Hernández⁷, Marisa Hernández⁸, Elia Valls-Pascual⁹, L. Martinez-Costa⁹, Agusti Sellas-Fernandez¹⁰, Miguel Cordero-Coma¹¹, Manuel Díaz-Llopis¹², Roberto Gallego¹², Jose L. García Serrano¹³, Norberto Ortego Centeno¹⁴, Angel Garcia-Aparicio¹⁵, Olga Maiz-Alonso¹⁶, Ana Blanco¹⁷, Cruz Fernandez-Espartero¹⁸, Vega Jovaní¹⁹, Diana Peiteado²⁰, Elena Aurrecoechea²¹, Amalia Sanchez-Andrade²², Enrique Minguez²³, Carmen Carrasco-Cubero²⁴, Alejandro Olivé-Marqués²⁵, Esteban Rubio-Romero²⁶, Francisco J. Toyos Sáenz de Miera²⁷, David Diaz-Valle²⁸, Joan Miquel Nolla²⁹, Marcelino Revenga Martínez³⁰, Santos Castañeda³¹, Jose M Herreras³², Alejandro Fonollosa³³, Ignacio Torre-Salaberri³⁴, Esperanza Pato Cour³⁵, Juan Cruz³⁶, Carlos Férnandez Cid³⁷, Miriam García-Arias³⁸, Miguel Angel Caracuel-Ruiz³⁹, Carlos Alberto Montilla-Morales⁴⁰, Antonio Atanes⁴¹, Félix Francisco⁴², Santos Insua⁴³, Senen González-Suárez⁴⁴, Fernando Gamero⁴⁵, Luis Francisco Linares⁴⁶, Fredeswinda I. Romero-Bueno⁴⁷, Raquel Almodóvar González⁴⁸, Julio Vázquez⁴⁹, A. Javier García-González⁵⁰, Oscar Ruiz Moreno⁵¹, Fernando Jiménez-Zorzo⁵¹, Javier Manero⁵¹, Santiago Muñoz Fernandez⁵², Fred Antón Pages⁵³, Myriam Gandía⁵⁴, Francisco Javier López Longo⁵⁵, Enrique Raya Álvarez⁵⁶, Paz Rodríguez-Cundín⁵⁷, Diana Prieto Peña², Monica Calderón Goercke², Enar Pons¹, José Luis Hernández³, Miguel Angel González-Gay¹ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Rheumatology, Hospital del Mar. Barcelona. Spain, Barcelona, Spain, ⁵Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁶Rheumatology, Hospital de Valme. Sevilla. Spain, Sevilla, Spain, ⁷Rheumatology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁸Ophthalmology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ⁹Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, ¹⁰Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ¹¹Ophthalmology, Hospital de León. Spain, León, Spain, ¹²Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, ¹³Ophthalmology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ¹⁴Medicine Department, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ¹⁵Rheumatology, Hospital de Toledo. Toledo. Spain, Toledo, Spain, ¹⁶Hospital Universitario Donostia. San Sebastian. Spain, Donostia, Spain, ¹⁷Ophtamology, Hospital Universitario Donostia. San Sebastian. Spain, San Sebastian, Spain, ¹⁸Rheumatology, Hospital de Móstoles. Madrid. Spain, Madrid, Spain, ¹⁹Rheumatology, Hospital General Universitario de Alicante. Spain, Alicante, Spain, ²⁰Rheumatology, Rheumatology, La Paz University Hospital, Madrid, Spain, ²¹Rheumatology, Hospital de Sierrallana, Torrelavega. Cantabria. Spain, Torrelavega, Spain, ²²Rheumatology, Hospital Lucus Augusti. Lugo. Spain, Lugo, Spain, ²³Ophthalmology, Hospital Clínico de Zaragoza. Spain, Zaragoza, Spain, ²⁴Hospital de Mérida. Spain, Mérida, Spain, ²⁵Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ²⁶Hospital Universitario Virgen del Rocío. Sevilla. Spain, Sevilla, Spain, ²⁷Hospital Virgen de La Macarena. Sevilla. Spain, Sevilla, Spain, ²⁸Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, ²⁹Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ³⁰Hospital Universitario Ramón y Cajal. Madrid. Spain, Madrid, Spain, ³¹Rheumatology, Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain, ³²Ophthalmology, Hospital Universitario, IOBA. Valladolid. Spain, Valladolid, Spain, ³³Ophthalmology, Hospital de Cruces. Bilbao. Spain, Bilbao, Spain, ³⁴Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ³⁵Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ³⁶Rheumatology, Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, ³⁷Ophthalmology, Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, ³⁸Hospital Universitario de la Princesa. Madrid. Spain, Madrid, Spain, ³⁹Rheumatology service, Hospital Universitario Reina Sofía. Córdoba. Spain, Córdoba, Spain, ⁴⁰Hospital Clínico Universitario de Salamanca. Spain, Salamanca, Spain, ⁴¹Complejo Hospitalario Universitario A Coruña. Spain, A Coruna, Spain, ⁴²Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ⁴³Rheumatology, Hospital Universitario Santiago de Compostela. La Coruña. Spain, La Coruña, Spain, ⁴⁴Rheumatology, Hospital de Cabueñes. Gijón. Spain, Gijón, Spain, ⁴⁵Rheumatology, Hospital San Pedro Alcántara. Cáceres. Spain, Cáceres, Spain, ⁴⁶Rheumatology, Hospital Virgen de la Arrixaca. Murcia. Spain, Murcia, Spain, ⁴⁷Section for Autoimmune Diseases, Rheumatology, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, ⁴⁸Rheumatology, Hospital Universitario Fundación Alcorcón. Madrid. Spain, Madrid, Spain, ⁴⁹Rheumatology, Hospital de Ferrol. La Coruña. Spain, La Coruña, Spain, ⁵⁰Rheumatology, Instituto de Investigación Hospital 12 de octubre. Madrid. Spain, Madrid, Spain, ⁵¹Ophthalmology and Rheumatology, Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, ⁵²Hospital Universitario Infanta Sofía. Madrid. Spain, San Sebastián de los Reyes (Madrid), Spain, ⁵³Rheumatology, Hospital Universitario Virgen del Rocío. Sevilla. Spain, Sevilla, Spain, ⁵⁴Rheumatology, Hospital Puerta del Mar. Cádiz. Spain, Cádiz, Spain, ⁵⁵Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ⁵⁶Rheumatology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ⁵⁷Preventive Medicine, Preventive Medicine. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain., Santander, Spain
Background/Purpose: Uveitis is one of the major causes of disability of Behçet's disease (BD). According to the “Expert panel recommendations” (Ophthalmology. 2014; 121:785-96), anti-TNF therapy…
Abstract Number: 1774 • 2018 ACR/ARHP Annual Meeting
The Relationship between Serum Cholinesterase, Dickkopf-1 and Number of Organ Involvement in Japanese Patients with IgG4-Related Disease
Hirofumi Nishikawa¹, Yoshinori Taniguchi¹, Satoshi Inotani¹, Mitsuhiro Kawano² and Yoshio Terada¹, ¹Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School Hospital, Nankoku, Japan, ²Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Japan
Background/Purpose: To evaluate the relationship between serum cholinesterase (ChE) level, number of organ involvement, serum fibrotic markers and imaginational outcomes in Japanese patients with IgG4-related…
Abstract Number: 1775 • 2018 ACR/ARHP Annual Meeting
IgG4-Related Disease, Clinical Series on Chilean Patients
Carolina Cuéllar¹, Oscar Neira^2,3, Alejandra Herrera⁴, Miguel Gutérrez⁵, Fabián Elgueta⁶, Pamela Wurmann⁶, Bellanides Mansilla^4,7, Javier Basualdo^2,8, Jorge Vega⁵, Daniel Erlij², Cristián Labarca³, Cristián Vergara⁵, Verónica Mezzano^9,10, Paula Pastenes¹¹, Lilith Stange¹², Susana Michalland², Francisco Silva³, Aquiles Jara¹³, I. Annelise Goecke⁶, Carolina Llanos⁹, María Badilla², Rodrigo Tagle¹³, Paula Burgos⁹, Mirentxu Iruretagoyena⁹, Patricio Sandoval¹⁴, Cristina Fernández¹⁵ and Carolina Landeros¹⁶, ¹Rheumatology Section., Hospital del Salvador, Universidad de Chile., SANTIAGO, Chile, ²Rheumatology Section., Hospital del Salvador, Universidad de Chile., Santiago, Chile, ³Rheumatology Unit, Clinica Alemana de Santiago. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile, ⁴Rheumatology Departament, Pontificia Universidad Católica de Chile., Santiago, Chile, ⁵Hospital Naval Almirante Nef, Viña del Mar., Viña del Mar, Chile, ⁶Rheumatology Section, Hospital Clínico Universidad de Chile, Santiago, Chile, ⁷Hospital Clínico Magallanes, Punta Arenas, Chile, ⁸Clínica Santa María de Santiago., Santiago, Chile, ⁹Rheumatology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, ¹⁰Clínica Las Condes., Santiago, Chile, ¹¹Hospital Carlos Van Buren, Valparaíso, Chile, ¹²Clínica Ciudad del Mar, Viña del Mar, Chile, ¹³Nephrology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, ¹⁴Neurology Departament., Pontificia Universidad Católica de Chile., Santiago, Chile, ¹⁵Instituto Nacional del Tórax., Santiago, Chile, ¹⁶Internal Medicine Service., Hospital del Salvador, Universidad de Chile., Santiago, Chile
Background/Purpose: IgG4-related disease (IgG4-RD) is a chronic fibroinflammatory condition that can affect almost any organ. Gold standard for diagnosis, biopsy, can shows lymphoplasmacytic infiltration, storiform…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].